| Novartis Pharma Schweiz AG - Ciproxin HC, Ohrentropfen, Suspension | | 54807 | | 01 | | Ciproxin HC | | Ohrentropfen, Suspension | | S02CA03 | | Hydrocortisone and Antiinfectives | | 22.12.1998 | | |
| | Composition | | ciprofloxacinum 2 mg ut ciprofloxacini hydrochloridum 2.329 mg, hydrocortisonum 10 mg, polysorbatum 20, natrii acetas trihydricus, acidum aceticum glaciale, lecithinum ex soja hydrogenatum, natrii chloridum, poly(alcohol vinylicus), aqua, alcohol benzylicus 9 mg, ad suspensionem pro 1 ml. | | Packungsbestandteile | | Ohrensuspension | | | | | | | | Active Agent | Dose |
|---|
| Ciprofloxacin | 2 mg correspond Ciprofloxacin Hydrochloride | | Hydrocortisone | 10 mg |
| | BAG: Active Agent | Dose |
|---|
| Ciprofloxacin | 2 mg | | Hydrocortisone | 10 mg |
| | | | Inactive agents | | additional_information |
|---|
| Alcohol Benzylicus | | conserv. |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 015 | 10 ml | 6.01 | 15.75 | B | SL | Yes |
|
|
